Ignite Creation Date:
2025-12-25 @ 2:55 AM
Ignite Modification Date:
2026-06-28 @ 8:40 PM
Study NCT ID:
NCT00779233
Status:
COMPLETED
Last Update Posted:
2008-10-24
First Post:
2008-10-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting Conditions
Sponsor:
Ranbaxy Laboratories Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
10440303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr. Tausif Monif
Old Organization:
Ranbaxy Research Labs